29 November 2016 : Laboratory Research
Isoflurane Promotes Non-Small Cell Lung Cancer Malignancy by Activating the Akt-Mammalian Target of Rapamycin (mTOR) Signaling Pathway
DOI: 10.12659/MSM.898434
Med Sci Monit 2016; 22:4644-4650
HTML version available soon